9/21/2012

The FDA approved Amgen's Prolia injection for use in increasing bone mass in male osteoporosis patients with high fracture risk. Prolia previously had been approved for use after menopause in women with the same condition and fracture risk.

Full Story:
Reuters

Related Summaries